Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, Mobility in sIBM Patients
Randomized, Double-blind, Placebo-controlled, Dose-finding Study to Evaluate Efficacy, Safety, Tolerability of i.v. BYM338 at 52 Weeks on Physical Function, Muscle Strength, and Mobility in Sporadic Inclusion Body Myositis Patients
Status: Enrolling
Updated:  3/25/2016
Novartis Investigative Site
mi
from
St. Leonards,
Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, Mobility in sIBM Patients
Randomized, Double-blind, Placebo-controlled, Dose-finding Study to Evaluate Efficacy, Safety, Tolerability of i.v. BYM338 at 52 Weeks on Physical Function, Muscle Strength, and Mobility in Sporadic Inclusion Body Myositis Patients
Status: Enrolling
Updated: 3/25/2016
Novartis Investigative Site
mi
from
St. Leonards,
Click here to add this to my saved trials
Instep Plantar Fasciotomy With and Without Gastrocnemius Recession
Surgical Treatment of Plantar Fasciitis: Instep Plantar Fasciotomy With and Without Gastrocnemius Recession
Status: Enrolling
Updated:  3/28/2016
Step Lively Foot and Ankle Center
mi
from
Dublin, OH
Instep Plantar Fasciotomy With and Without Gastrocnemius Recession
Surgical Treatment of Plantar Fasciitis: Instep Plantar Fasciotomy With and Without Gastrocnemius Recession
Status: Enrolling
Updated: 3/28/2016
Step Lively Foot and Ankle Center
mi
from
Dublin, OH
Click here to add this to my saved trials
Instep Plantar Fasciotomy With and Without Gastrocnemius Recession
Surgical Treatment of Plantar Fasciitis: Instep Plantar Fasciotomy With and Without Gastrocnemius Recession
Status: Enrolling
Updated:  3/28/2016
Foot and Ankle Specialists of Central Ohio
mi
from
Gahanna, OH
Instep Plantar Fasciotomy With and Without Gastrocnemius Recession
Surgical Treatment of Plantar Fasciitis: Instep Plantar Fasciotomy With and Without Gastrocnemius Recession
Status: Enrolling
Updated: 3/28/2016
Foot and Ankle Specialists of Central Ohio
mi
from
Gahanna, OH
Click here to add this to my saved trials
Instep Plantar Fasciotomy With and Without Gastrocnemius Recession
Surgical Treatment of Plantar Fasciitis: Instep Plantar Fasciotomy With and Without Gastrocnemius Recession
Status: Enrolling
Updated:  3/28/2016
Step Lively Foot and Ankle Center
mi
from
Grove City, OH
Instep Plantar Fasciotomy With and Without Gastrocnemius Recession
Surgical Treatment of Plantar Fasciitis: Instep Plantar Fasciotomy With and Without Gastrocnemius Recession
Status: Enrolling
Updated: 3/28/2016
Step Lively Foot and Ankle Center
mi
from
Grove City, OH
Click here to add this to my saved trials
Instep Plantar Fasciotomy With and Without Gastrocnemius Recession
Surgical Treatment of Plantar Fasciitis: Instep Plantar Fasciotomy With and Without Gastrocnemius Recession
Status: Enrolling
Updated:  3/28/2016
Step Lively Foot and Ankle Center
mi
from
Reynoldsburg, OH
Instep Plantar Fasciotomy With and Without Gastrocnemius Recession
Surgical Treatment of Plantar Fasciitis: Instep Plantar Fasciotomy With and Without Gastrocnemius Recession
Status: Enrolling
Updated: 3/28/2016
Step Lively Foot and Ankle Center
mi
from
Reynoldsburg, OH
Click here to add this to my saved trials
Evaluation of the Practice of Three Morning Sputa on Separate Days for Diagnosis of Mtb
Evaluation of the Practice of Three Morning Sputa on Separate Days for Diagnosis of Mtb
Status: Enrolling
Updated:  3/29/2016
NYU School of Medicine Division of Pulmonary and Critical Care
mi
from
New York, NY
Evaluation of the Practice of Three Morning Sputa on Separate Days for Diagnosis of Mtb
Evaluation of the Practice of Three Morning Sputa on Separate Days for Diagnosis of Mtb
Status: Enrolling
Updated: 3/29/2016
NYU School of Medicine Division of Pulmonary and Critical Care
mi
from
New York, NY
Click here to add this to my saved trials
How Does the Clinical Tool 'What's Going Around' Affect Clinical Practice
How Does the Clinical Tool 'What's Going Around' Affect Clinical Practice
Status: Enrolling
Updated:  3/30/2016
NorthShore University HealthSystem
mi
from
Evanston, IL
How Does the Clinical Tool 'What's Going Around' Affect Clinical Practice
How Does the Clinical Tool 'What's Going Around' Affect Clinical Practice
Status: Enrolling
Updated: 3/30/2016
NorthShore University HealthSystem
mi
from
Evanston, IL
Click here to add this to my saved trials
Glutamine Challenge as Predictor of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS)
Glutamine Challenge as Predictor of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS)
Status: Enrolling
Updated:  3/30/2016
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Glutamine Challenge as Predictor of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS)
Glutamine Challenge as Predictor of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS)
Status: Enrolling
Updated: 3/30/2016
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Glutamine Challenge as Predictor of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS)
Glutamine Challenge as Predictor of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS)
Status: Enrolling
Updated:  3/30/2016
University of Montreal
mi
from
Montreal,
Glutamine Challenge as Predictor of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS)
Glutamine Challenge as Predictor of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS)
Status: Enrolling
Updated: 3/30/2016
University of Montreal
mi
from
Montreal,
Click here to add this to my saved trials
Evaluating the Safety, Tolerability, and Immunogenicity of a Tetravalent Dengue Vaccine (V180) in Healthy Adults Who Previously Received a Live-Attenuated Tetravalent Vaccine (TV003 or TV005)
A Phase I Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Tetravalent Recombinant Subunit Dengue Vaccine (V180) in Healthy Adults Who Previously Received a Live-Attenuated Tetravalent Vaccine (TV003 or TV005)
Status: Enrolling
Updated:  3/31/2016
Center for Immunization Research, Johns Hopkins School of Public Health
mi
from
Baltimore, MD
Evaluating the Safety, Tolerability, and Immunogenicity of a Tetravalent Dengue Vaccine (V180) in Healthy Adults Who Previously Received a Live-Attenuated Tetravalent Vaccine (TV003 or TV005)
A Phase I Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Tetravalent Recombinant Subunit Dengue Vaccine (V180) in Healthy Adults Who Previously Received a Live-Attenuated Tetravalent Vaccine (TV003 or TV005)
Status: Enrolling
Updated: 3/31/2016
Center for Immunization Research, Johns Hopkins School of Public Health
mi
from
Baltimore, MD
Click here to add this to my saved trials
Evaluating the Safety, Tolerability, and Immunogenicity of a Tetravalent Dengue Vaccine (V180) in Healthy Adults Who Previously Received a Live-Attenuated Tetravalent Vaccine (TV003 or TV005)
A Phase I Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Tetravalent Recombinant Subunit Dengue Vaccine (V180) in Healthy Adults Who Previously Received a Live-Attenuated Tetravalent Vaccine (TV003 or TV005)
Status: Enrolling
Updated:  3/31/2016
University of Vermont Medical Center
mi
from
Burlington, VT
Evaluating the Safety, Tolerability, and Immunogenicity of a Tetravalent Dengue Vaccine (V180) in Healthy Adults Who Previously Received a Live-Attenuated Tetravalent Vaccine (TV003 or TV005)
A Phase I Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Tetravalent Recombinant Subunit Dengue Vaccine (V180) in Healthy Adults Who Previously Received a Live-Attenuated Tetravalent Vaccine (TV003 or TV005)
Status: Enrolling
Updated: 3/31/2016
University of Vermont Medical Center
mi
from
Burlington, VT
Click here to add this to my saved trials
Evaluating the Safety, Tolerability, and Immunogenicity of a Tetravalent Dengue Vaccine (V180) in Healthy Adults Who Previously Received a Live-Attenuated Tetravalent Vaccine (TV003 or TV005)
A Phase I Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Tetravalent Recombinant Subunit Dengue Vaccine (V180) in Healthy Adults Who Previously Received a Live-Attenuated Tetravalent Vaccine (TV003 or TV005)
Status: Enrolling
Updated:  3/31/2016
University of Vermont Vaccine Testing Center
mi
from
Burlington, VT
Evaluating the Safety, Tolerability, and Immunogenicity of a Tetravalent Dengue Vaccine (V180) in Healthy Adults Who Previously Received a Live-Attenuated Tetravalent Vaccine (TV003 or TV005)
A Phase I Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Tetravalent Recombinant Subunit Dengue Vaccine (V180) in Healthy Adults Who Previously Received a Live-Attenuated Tetravalent Vaccine (TV003 or TV005)
Status: Enrolling
Updated: 3/31/2016
University of Vermont Vaccine Testing Center
mi
from
Burlington, VT
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
Chandler, AZ
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
Chandler, AZ
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
Jonesboro, AR
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
Jonesboro, AR
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
Little Rock, AR
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
Sacramento, CA
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
Longmont, CO
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
Longmont, CO
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
Norwich, CT
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
Norwich, CT
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
Miami Beach, FL
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
Marietta, GA
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
Marietta, GA
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
Woodstock, GA
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
Woodstock, GA
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
Bardstown, KY
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
Bardstown, KY
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
Crestview Hills, KY
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
Crestview Hills, KY
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
Louisville, KY
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
Madisonville, KY
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
Madisonville, KY
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
Haughton, LA
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
Haughton, LA
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
Metairie, LA
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
Metairie, LA
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
Woburn, MA
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
Woburn, MA
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
Plymouth, MN
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
Plymouth, MN
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
Rochester, NY
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
Cleveland, OH
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
Pittsburgh, PA
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
Warwick, RI
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
Warwick, RI
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
mi
from
Barnwell, SC
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
mi
from
Barnwell, SC
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
Rapid City, SD
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
Rapid City, SD
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
Kingsport, TN
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
Kingsport, TN
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
Austin, TX
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
Ft. Worth, TX
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
Ft. Worth, TX
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
San Antonio, TX
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
Orem, UT
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
Orem, UT
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
South Jordan, UT
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
South Jordan, UT
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
Midlothian, VA
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
Midlothian, VA
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
Vienna, VA
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
Vienna, VA
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
Spokane, WA
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated:  4/1/2016
Clinical Research Facility
mi
from
Marshfield, WI
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
Status: Enrolling
Updated: 4/1/2016
Clinical Research Facility
mi
from
Marshfield, WI
Click here to add this to my saved trials
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated:  4/1/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated: 4/1/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated:  4/1/2016
University of Mississippi Medical Center
mi
from
Jackson, MS
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated: 4/1/2016
University of Mississippi Medical Center
mi
from
Jackson, MS
Click here to add this to my saved trials
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated:  4/1/2016
Columbia University
mi
from
New York, NY
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated: 4/1/2016
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated:  4/1/2016
Mission Hospital
mi
from
Ashville, NC
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated: 4/1/2016
Mission Hospital
mi
from
Ashville, NC
Click here to add this to my saved trials